Chemoprevention of Colorectal Cancer
- PMID: 31563626
- PMCID: PMC6981249
- DOI: 10.1053/j.gastro.2019.06.047
Chemoprevention of Colorectal Cancer
Abstract
Although colorectal cancer (CRC) screening has reduced the incidence of and mortality from CRC, chemoprevention strategies have the potential to further reduce CRC incidence and mortality. Chemoprevention agents might be used for average-risk as well as high-risk groups, and to prevent CRC recurrence after therapy. CRC chemoprevention agents that have been studied include aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, statins, agents that target metabolic pathways, and vitamins and minerals. We review the prospect of chemoprevention of CRC, results from preclinical and human studies, challenges, and future directions.
Keywords: Adenoma; Chemoprevention; Colorectal Cancer.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- American Cancer Society. Global Cancer Facts & Figures 4th Edition American Cancer Society, 2018. Accessible at https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-....
-
- American Cancer Society. Cancer Facts & Figures 2019. American Cancer Society, 2019. Accessible at https://www.cancer.org/latest-news/facts-and-figures-2019.html.
-
- Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med 2013;369:1106–14. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
